Medicalook
Medicalook

Zomig

http://www.medicalook.com
Zomig

Zomig review





Zomig is a brand name for zolmitriptan and belongs to a class of drugs called triptans which are used to treat the pain, aura, and other symptoms of migraine headaches. It is to be used for the acute treatment of migraines, either with or without auras. It is not intended to be used as a preventative treatment, or for the treatment of hemiplegic migraines, basilar migraines, or cluster headaches.

Most people find that Zomig begins to work within thirty minutes, and that they are able to resume their normal activities within two hours. Zomig is administered in tablets, orally disintegrating tablets, and nasal spray, and should be taken as soon as a migraine begins, or as soon as you are able to do so. While Zomig is indicated for migraine, studies have shown that it also proves very effective in the relief of cluster headaches, a very painful type of headache that is not treated by other types of migraine medications.

The most serious side effects of Zomig use include serious cardiac events, including some that have been fatal. These events include coronary artery vasospasm, heart attack, transient myocardial ischemia, ventricular tachycardia, and ventricular fibrillation. Other side effects may include tingling or numbness of the hands or feet, flushing or hot flashes, tightness or pressure in the chest, abdominal pain or discomfort, tightness or discomfort of the throat, nausea, dizziness, sleepiness, or headache. Other rare side effects may include back pain, fever or other flu-like symptoms, rheumatoid arthritis, high blood pressure, loss of appetite, constipation, diarrhea, increased salivation, weight gain or weight loss, bone pain, anxiety, abnormal dreams, depression, tremor, nervousness, abnormal gait, or sore throat. You may also experience asthma, respiratory tract infection, runny nose, yawning, coughing, sweating, light sensitivity, ringing in the ears, dry eyes, ear infections, urinary frequency, breast pain, irregular periods, or vaginitis. Zomig is generally well tolerated, and these side effects have usually proven to be mild and to pass quickly.

Zomig is only intended for use where a diagnosis of migraine has been clearly established. It should not be used with certain drugs, and especially within 72 hours of antidepressants such as ketoconazole, itraconazole, nelfinavir, ritonavir, nefazodone, clarithromycin, or troleandomycin. It should also not be used in conjunction with a class of drugs called CYP3A4-inhibitors, as serious heart-related reactions can occur. You should not take Zomig if you have high blood pressure, heart disease or a history of heart disease, liver problems, or an allergy to any of its ingredients.

Zomig is in Pregnancy Category C, which means that it is not known whether it is safe for pregnant women to take it. It should not be given to pregnant women unless the potential benefits clearly outweigh any risk to the fetus. Zomig does appear in breast milk in very small doses, so caution should be used if you take it while nursing a child. It is not know whether Zomig is safe to use in children.

Zomig has the following structural formula:

Chemical structure of zomig


• Molecular formula of zomig is C16H21N3O2
• Chemical IUPAC Name is (4R)-4-[[3-(2-dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one
• Molecular weight is 287.357 g/mol
Zomig available : 2.5mg tablets, 5mg tablets

Generic name: Zolmitriptan

  Your Zomig review